1. I n t e g r i t y - S e r v i c e - E x c e l l e n c e Headquarters U.S. Air Force Small Business Innovation Research (SBIR) Brief Dr. Sirie Blankenship Sherrilynne Cherry June 12, 2013

2.  What is AFMS SBIR?  AFMS Biomedical SBIR Organizational Structure  DHP SBIR Program  AFMS Current Topics  Benefits to Participate  DoD Solicitation Schedule  DoD SBIR FY12 Statistics 2

3.  Established Air Force Medical Service (AFMS) involvement  Identified gap and defined plan in 2008  First topic submitted by Air Force Medical Support Agency (San Antonio) and approved July 2009; first in history of AFMS  Established Phase I and II management support in July 2009 with no additional resources  Annual topic submissions  Evaluator training  Proposal review and selection  Financial and Contract management  Recurring and scientific reports  PI program management support  Liaison with Air Force Medical Service regulatory bodies 3

4.  Program is administered by the AFMS Office of Research Applications and Technology (ORTA)  Program Participants  AFMS topic authors (Government Employee or Military)  Small Business  The AFMS Biomedical SBIR Program is an extension of the Defense Health Program's (DHP) SBIR Program  The DHP SBIR funding comes from the Office of Secretary of Defense Health Affairs, OASD (HA) to the US Army Medical Research & Material Command (USAMRMC) and the money is then transferred to the AFMS, Navy, etc. 4

5.  OSD09-H23 Advancements in Retinal Imaging for Diagnosis of Mild Traumatic Brain Injury  5 Phase I proposals – 3 awards  2 Phase II invites/proposals – 1 award  Results:  $1,049,808 additional R&D dollars to AFMS  Novel device advancing to Phase III – commercialization 5

6.  OSD10-H09 Synthetic Tissue Trainer and 0SD10- H08 Medical Gaming  46 Phase I proposals – 11awards  11 Phase II invites/proposals – 3 awards  Results:  $2,976,575 additional R&D dollars to AFMS  Novel training devices advancing to Phase III 6

7.  OSD11-H06 Improved Coupling Factor of Personal Cooling Systems  22 Phase I proposals – 4 awards  2 Phase II invites/proposals – proposals received 10 Sep 12  Results:  Estimated $2,599,815 additional R&D dollars to AFMS 7

8.  DHP13-013 : A Point-of-Care Device for Diagnosis of Platelet Injury in Trauma Patients  DHP13-014 : Tailored Wound Dressing for the Treatment of Burns  These topics can be viewed at: http://www.acq.osd.mil/osbp/sbir/sb/schedule.shtml  Topic Questions can be asked via the DoD SBIR/STTR SITIS (SBIR/STTR Interactive Topic Information System) located at http://www.dodsbir.net/sitis/ 8

9.  Small Business:  Largest source of early stage R&D funds for small business  No strings attached - company retains data rights for 4 years (5 for DoD)  Follow on awards are made in a non-competitive way  Builds credibility of company’s research  Company can maintain ownership of equipment purchased under Phase I and II  Government:  Safe way to try out high-risk R&D  Small business are often more cost effective and innovative then large primes (i.e. agile, niche)  Helps new companies establish a track record with the government (test drive)  Allows program managers to establish 2 nd source/method for R&D/equipment and augment their ongoing programs (risk management) 9

10. 10 Currently DHP SBIR program participates in the DOD SBIR 2013.2 solicitation schedule. The DHP SBIR program will be moving to the 2014.1 solicitation schedule. Solicitation will be announced in June 2013.

11. 11

12. QUESTIONS?

13. 13 Funding Activity Phase I Feasibility DoD wide solicitation Phase II Demonstration Components invite proposals Phase III Commercialization Non-competitive ~ $150K ~ $1M Base Varying multiple Options Gated Phase II Any Non-SBIR Funding (Government or Private) 6 months Determine Scientific or Technical Merit 2 Years Prototype Development & Demonstration Final Development & Production For sale in commercial and/or Defense markets